An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED

Clinical trial NCT07519902 · RECRUITING

Trial details

NCT number: NCT07519902
Sponsor: Dompé Farmaceutici S.p.A
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Persistent Corneal Epithelial Defect

Start date: 2026-06-02
Primary completion: 2027-12-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.